{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:19Z","timestamp":1740144139070,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Support","award":["20191903"],"award-info":[{"award-number":["20191903"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>So far, the recovery quality after general anesthesia is still unsatisfied. Nalmefene is a drug to treat opioid overdose and reverse opioid actions. We aim to investigate the efficacy of nalmefene on optimizing the recovery quality of patients after general anesthesia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>It is a prospective, placebo-controlled, two-arm parallel groups, multicentre, double-blind, randomized (PPPMDR) clinical trial. The participants (<jats:italic>n<\/jats:italic>\u2009=\u2009520) will be randomly assigned into two groups. Each patient will receive either: a single dose of nalmefene 0.25\u00a0\u00b5g\/kg in the intervention group, or the same volume of 0.9% NaCl solution in the control group at the end of the surgery. The primary outcome will be the time interval between the end of anaesthesia and recovery endpoints achieved (Aldrete recovery score\u2009\u2265\u20099) in post-anesthesia care unit (PACU). The other variables are the time interval from the end of operation to extubation; Richmond Agitation Sedation Scale (RASS) score at extubation; the time at Montreal Cognitive Assessment Scale (MoCA) orientation score\u2009\u2265\u20095; visual analog scale (VAS) score and adverse effects including postoperative nausea and vomiting (PONV), and pruritus in PACU and 24\u00a0h postoperatively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Analysis<\/jats:title>\n                <jats:p>This trial aims to study whether small dose of nalmefene can shorten the time from the end of surgery to Aldrete score\u2009\u2265\u20099 and improve opioid-induced side effects.This trial focuses on providing the reliable clinical evidence for satisfactory quality of recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ethics and dissemination<\/jats:title>\n                <jats:p>This clinical trial has been approved and supported by the ethics committee of the Renji Hospital, Shanghai Jiaotong University, School of Medicine (KY2020-150); Shanghai Tongren Hospital (2021\u2013030-01);The First Affiliated Hospital of Guangxi Medical University (2021\u2013032); and The First Affiliated Hospital of Zhengzhou University(2021-KY-0495\u2013003). Analysis of the study results will be submitted to a peer-reviewed journal for publication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov, NCT04713358, Registered on September 23, 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07169-4","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:03:13Z","timestamp":1677654193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy of nalmefene on anesthetic recovery of patients: a study protocol for a multicenter randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaowen","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jueying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiueyue","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Huai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-1025","authenticated-orcid":false,"given":"Diansan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"issue":"Suppl 2","key":"7169_CR1","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S2214-109X(15)70087-2","volume":"3","author":"J Rose","year":"2015","unstructured":"Rose J, et al. Estimated need for surgery worldwide based on prevalence of diseases: a modelling strategy for the WHO Global Health Estimate. Lancet Glob Health. 2015;3(Suppl 2):S13-20.","journal-title":"Lancet Glob Health"},{"issue":"9399","key":"7169_CR2","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(03)14966-5","volume":"362","author":"H Kehlet","year":"2003","unstructured":"Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362(9399):1921\u20138.","journal-title":"Lancet"},{"issue":"6","key":"7169_CR3","first-page":"537","volume":"22","author":"EA Frost","year":"2014","unstructured":"Frost EA. Differential diagnosis of delayed awakening from general anesthesia: a review. Middle East J Anaesthesiol. 2014;22(6):537\u201348.","journal-title":"Middle East J Anaesthesiol"},{"issue":"5","key":"7169_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bjae.2020.01.007","volume":"20","author":"E Thomas","year":"2020","unstructured":"Thomas E, Martin F, Pollard B. Delayed recovery of consciousness after general anaesthesia. BJA Educ. 2020;20(5):173\u20139.","journal-title":"BJA Educ"},{"key":"7169_CR5","doi-asserted-by":"crossref","unstructured":"Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11(2 Suppl):S133-53.","DOI":"10.36076\/ppj.2008\/11\/S133"},{"issue":"3","key":"7169_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/alcalc\/agaa015","volume":"55","author":"A Braillon","year":"2020","unstructured":"Braillon A. Nalmefene as Needed Use Needs Evidence for Harm\/Benefit Ratio. Alcohol Alcohol. 2020;55(3):337.","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"7169_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12962","volume":"26","author":"N Tournier","year":"2021","unstructured":"Tournier N, et al. Nalmefene alleviates the neuroimmune response to repeated binge-like ethanol exposure: A TSPO PET imaging study in adolescent rats. Addict Biol. 2021;26(3): e12962.","journal-title":"Addict Biol"},{"key":"7169_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108590","volume":"192","author":"KA Windisch","year":"2021","unstructured":"Windisch KA, et al. Nalmefene, a mu opioid receptor antagonist\/kappa opioid receptor partial agonist, potentiates cocaine motivation but not intake with extended access self-administration in adult male mice. Neuropharmacology. 2021;192: 108590.","journal-title":"Neuropharmacology"},{"issue":"4","key":"7169_CR9","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1097\/00000542-200004000-00018","volume":"92","author":"TB Dougherty","year":"2000","unstructured":"Dougherty TB, Porche VH, Thall PF. Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesia. Anesthesiology. 2000;92(4):1010\u20136.","journal-title":"Anesthesiology"},{"issue":"2","key":"7169_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s11596-020-2170-8","volume":"40","author":"MY Li","year":"2020","unstructured":"Li MY, et al. Effect of Nalmefene on Delayed Neurocognitive Recovery in Elderly Patients Undergoing Video-assisted Thoracic Surgery with One Lung Ventilation. Curr Med Sci. 2020;40(2):380\u20138.","journal-title":"Curr Med Sci"},{"issue":"1","key":"7169_CR11","first-page":"461","volume":"24","author":"NL Zhang","year":"2020","unstructured":"Zhang NL, et al. Effects of nalmefene hydrochloride on TLR4 signaling pathway in rats with lung ischemia-reperfusion injury. Eur Rev Med Pharmacol Sci. 2020;24(1):461\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"7169_CR12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler CN, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338\u201344.","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"7169_CR13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1001\/jama.291.14.1753","volume":"291","author":"EW Ely","year":"2004","unstructured":"Ely EW, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753\u201362.","journal-title":"JAMA"},{"issue":"2","key":"7169_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gps.4756","volume":"33","author":"N Carson","year":"2018","unstructured":"Carson N, Leach L, Murphy KJ. A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry. 2018;33(2):379\u201388.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"7169_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12871-021-01287-9","volume":"21","author":"C Robert","year":"2021","unstructured":"Robert C, et al. Cognitive status of patients judged fit for discharge from the post-anaesthesia care unit after general anaesthesia: a randomized comparison between desflurane and propofol. BMC Anesthesiol. 2021;21(1):76.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"7169_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00405-016-4220-1","volume":"274","author":"S Karabayirli","year":"2017","unstructured":"Karabayirli S, et al. Surgical conditions during FESS; comparison of dexmedetomidine and remifentanil. Eur Arch Otorhinolaryngol. 2017;274(1):239\u201345.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"7169_CR17","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1590\/S0080-62342012000400013","volume":"46","author":"FS de Castro","year":"2012","unstructured":"de Castro FS, et al. Body temperature, Aldrete-Kroulik index, and patient discharge from the post-anesthetic recovery unit. Rev Esc Enferm USP. 2012;46(4):872\u20136.","journal-title":"Rev Esc Enferm USP"},{"issue":"2","key":"7169_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/0310057X8701500209","volume":"15","author":"J Zelcer","year":"1987","unstructured":"Zelcer J, Wells DG. Anaesthetic-related recovery room complications. Anaesth Intensive Care. 1987;15(2):168\u201374.","journal-title":"Anaesth Intensive Care"},{"issue":"6","key":"7169_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.4187\/respcare.02926","volume":"59","author":"CA Artime","year":"2014","unstructured":"Artime CA, Hagberg CA. Tracheal extubation. Respir Care. 2014;59(6):991\u20131002 discussion 1002\u20135.","journal-title":"Respir Care."},{"issue":"6","key":"7169_CR20","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/j.bja.2018.12.023","volume":"122","author":"MH Algera","year":"2019","unstructured":"Algera MH, et al. Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal. Br J Anaesth. 2019;122(6):e168\u201379.","journal-title":"Br J Anaesth"},{"issue":"3","key":"7169_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0736-4679(98)00019-5","volume":"16","author":"DS Wang","year":"1998","unstructured":"Wang DS, Sternbach G, Varon J. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine. J Emerg Med. 1998;16(3):471\u20135.","journal-title":"J Emerg Med"},{"issue":"7","key":"7169_CR22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s11095-021-03069-x","volume":"38","author":"F Sharifi","year":"2021","unstructured":"Sharifi F, et al. Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose. Pharm Res. 2021;38(7):1221\u201334.","journal-title":"Pharm Res"},{"issue":"1","key":"7169_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuroscience.2005.06.003","volume":"135","author":"HY Wang","year":"2005","unstructured":"Wang HY, et al. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Neuroscience. 2005;135(1):247\u201361.","journal-title":"Neuroscience"},{"issue":"2","key":"7169_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1124\/jpet.118.256115","volume":"371","author":"P Krieter","year":"2019","unstructured":"Krieter P, et al. Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose. J Pharmacol Exp Ther. 2019;371(2):409\u201315.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"7169_CR25","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.npp.1300811","volume":"30","author":"G Bart","year":"2005","unstructured":"Bart G, et al. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? Neuropsychopharmacology. 2005;30(12):2254\u201362.","journal-title":"Neuropsychopharmacology"},{"key":"7169_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2014.05.044","volume":"738","author":"Z Yong","year":"2014","unstructured":"Yong Z, et al. Nalmefene reverses carfentanil-induced loss of righting reflex and respiratory depression in rats. Eur J Pharmacol. 2014;738:153\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"7169_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1053\/ajem.2001.27141","volume":"19","author":"A Chumpa","year":"2001","unstructured":"Chumpa A, et al. Nalmefene for elective reversal of procedural sedation in children. Am J Emerg Med. 2001;19(7):545\u20138.","journal-title":"Am J Emerg Med"},{"issue":"4","key":"7169_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/00000542-199904000-00013","volume":"90","author":"GP Joshi","year":"1999","unstructured":"Joshi GP, et al. Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia. Anesthesiology. 1999;90(4):1007\u201311.","journal-title":"Anesthesiology"},{"issue":"22","key":"7169_CR29","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1001\/jama.289.22.2983","volume":"289","author":"EW Ely","year":"2003","unstructured":"Ely EW, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983\u201391.","journal-title":"JAMA"},{"issue":"4","key":"7169_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139.","journal-title":"J Am Geriatr Soc"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07169-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T07:03:55Z","timestamp":1677654235000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07169-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7169"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07169-4","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"18 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical trial has been approved and supported by the ethics committee of the Renji Hospital, Shanghai Jiaotong University, School of Medicine(KY2020-150).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Provided in supplementary materials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}